Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The goal of this investigator-initiated, single-center, randomized controlled trial (RCT) is to compare the effects of four weeks of three therapies on clinical and mechanistic outcomes based on pH-Imp testing using a three-arm parallel design in NICU infants with objective GERD diagnosis. The three therapies being compared are natural maturation, proton pump inhibitor (PPI) use, and added rice (AR) formula use. The main goals are:
Full description
In consented subjects, eligibility is determined after initial diagnostic 24-hour pH Impedance test. These subjects will be randomized to one of the 3 arms of the study (natural maturation, PPI, AR formula) for 4 weeks of treatment. A second 24-hour pH Impedance test will be done on therapy at 4 weeks or before discharge, whichever occurs first. Primary outcome will also be measured at 4 weeks or at discharge, whichever comes first.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
NICU infants of any gestational age who are between 37 - 47 weeks postmenstrual age at inception of the study meeting the following requirements:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
369 participants in 3 patient groups
Loading...
Central trial contact
Patty Luzader; Erika K Osborn
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal